Antimicrobial Agents and Chemotherapy, July 1999, p. 1533-1541, Vol. 43, No. 7
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Why Metronidazole Is Active against both Bacteria and Parasites
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115
| |
HISTORY OF METRONIDAZOLE USE: PARASITES CAME FIRST |
|---|
Metronidazole is one of the rare examples of a drug developed against a parasite which has since gained broad use as an antibacterial agent (24). Briefly, at Rhone-Poulenc labs in France, extracts of Streptomyces spp. were screened for activity against Trichomonas vaginalis, a cause of vaginal itching. Azomycin, a nitroimidazole, was identified, and metronidazole, a synthetic derivative, was used to treat chronic trichomonad infections, beginning in 1959 (66). Metronidazole was shown to be efficacious against Entamoeba histolytica, the cause of amebic dysentery and liver abscess, in 1966 (67). Giardia lamblia (also known as G. duodenalis) was treated with metronidazole after this luminal parasite was recognized as a cause of malabsorption and epigastric pain in the 1970s (102).
The antibacterial activity of metronidazole was discovered by accident in 1962 when metronidazole cured a patient of both trichomonad vaginitis and bacterial gingivitis (78). However, it was not until the 1970s that metronidazole was popularized for treatment of infections caused by gram-negative anaerobes such as bacteroides or gram-positive anaerobes such as clostridia (24, 48). Presently, metronidazole, which is inexpensive, has good tissue penetration, and produces relatively mild side effects, is on the formulary at most hospitals for prophylaxis against anaerobic infection after bowel surgery, for treatment of wound abscess, and for treatment of antibiotic-associated colitis caused by Clostridium difficile (85, 94). Metronidazole is an important part of combination therapy against Helicobacter pylori, a major cause of gastritis and a risk factor for stomach cancer (21, 57).
| |
NEW IDEAS ABOUT METRONIDAZOLE-SENSITIVE PARASITES |
|---|
Luminal parasites have two characteristics which distinguish them from other eukaryotes: (i) they live under anaerobic conditions, and (ii) they lack mitochondria and enzymes of oxidative phosphorylation (61). Indeed, a widely held view is that luminal parasites are "living fossils," which reflect eukaryotic lifestyles prior to oxygenation of the planet and acquisition of the mitochondrial endosymbiont (2, 9, 68). This conclusion is supported by the presence of amebae, giardia, and trichomonads at or near the bases of the eukaryotic phylogenetic trees constructed from small subunit rRNA sequences (82). Further, these luminal parasites lack centrioles, Golgi with tight lamellae (giardia and amebae), and introns (giardia and trichomonads) (1, 26, 51, 55, 81).
Recent studies of metronidazole-sensitive parasites suggest that these organisms are not living fossils but instead are diverse eukaryotes with novel adaptations to their anaerobic niche. First, amebae and giardia lack fermentation enzymes (lactate dehydrogenase and pyruvate decarboxylase), which are present in yeast and other eukaryotes (60, 90). Second, luminal parasites appear to have acquired by horizontal transfer bacterial genes which encode fermentation enzymes (72, 80). These include an iron-sulfur protein called pyruvate:ferredoxin oxidoreductase (POR), which is involved in metronidazole activation (36, 64, 88). Third, all of these "amitochondriate" parasites have a gene encoding a homologue of the mitochondrial 60-kDa heat shock protein (Hsp60) (11, 15, 32, 34, 70, 71). The trichomonad mitochondrion has been converted into a fermentation factory called "hydrogenosome" (5, 8, 11-13, 36, 40, 62). The mitochondrion-derived organelle of amebae is atrophic, while that of giardia may have been lost (26, 52, 71, 84).
The goals of this review are to (i) demonstrate how luminal parasites are similar to and different from each other, (ii) discuss the biochemistry and phylogeny of bacterium-like fermentation enzymes involved in metronidazole activation, (iii) explore the peculiar compartmentalization of these fermentation enzymes, and (iv) discuss mechanisms of metronidazole resistance in these parasites. Readers are referred to recent reviews of the clinical uses of metronidazole and of metronidazole resistance in H. pylori and other anaerobic bacteria (24, 30, 48, 57, 64, 85, 89, 94, 102).
| |
DIVERSE MORPHOLOGY OF METRONIDAZOLE-SENSITIVE ORGANISMS |
|---|
The bacteria and parasites treated with metronidazole, which share an anaerobic niche in the lumen of the bowel or vagina and in tissue abscesses, show little resemblance to each other (61). For example, amebae have a large cytosol that is filled with vesicles and vacuoles that resemble those of macrophages (55). Like macrophages, amebae phagocytose bacteria, including anaerobic bacteria such as Clostridia spp. or facultative anaerobes such as Escherichia coli (59). Giardias have two identical nuclei, multiple flagellae, and a sucker disc, which is composed of a set of unique cytoskeletal proteins called "giardins" (1, 26). Trichomonads alternate between an ameboid form, which phagocytoses bacteria like entamoebae, and a flagellated form, which moves somewhat as do giardias (66). In the pouch or rumen of bicloved mammals (e.g., sheep or cows), cellulose is degraded by anaerobic bacteria, as well as anaerobic fungi and ciliates (14). The rumen fungi (e.g., Neocallimastix, Piromyces, and Orpinomyces) are filamentous and resemble the more familiar hyphal fungi, which are facultative anaerobes, such as Aspergillus and Candida (92). The rumen ciliates (e.g., Polyplastron and Dasytricha), which are covered with cilia, resemble their aerobic counterparts, such as Paramecium and Tetrahymena (20, 33, 65).
| |
DIVERSE PHYLOGENY OF METRONIDAZOLE-SENSITIVE EUKARYOTES |
|---|
In the absence of fossil evidence, which might be used to dissect the history of metronidazole-sensitive eukaryotes, comparisons of small subunit rRNA (ssRNA) sequences may be used to reconstruct the phylogeny of these organisms and their aerobic counterparts (53, 82). Remarkably, the amitochondriate eukaryotes are distributed almost as broadly throughout the ssRNA tree as are the aerobic eukaryotes (Fig. 1). Giardia and trichomonads, which are distinct from each other, as evidenced by their long branch lengths, are at the root of the ssRNA tree, along with microsporidia. Microsporidia are opportunistic, intracellular parasites, which lack a mitochondrion (35). Amebae and rumen ciliates are in the middle of the tree, along with apicomplexa (cause of malaria and toxoplasmosis), kinetoplastids (cause of sleeping sickness and visceral leishmaniasis), and slime molds. Anaerobic and aerobic ciliates are not separated into separate groups or clades (20). Rumen fungi are at the crown of the ssRNA tree, along with other fungi, plants, and animals. It appears then that the luminal protozoan parasites, rumen fungi, and rumen ciliates do not have an immediate common ancestor. Similar adaptations made by these organisms to their anaerobic environment, therefore, are most likely examples of convergent evolution (5, 72).
|
| |
POR IS INVOLVED IN ACTIVATING METRONIDAZOLE IN ANAEROBIC BACTERIA AND LUMINAL PARASITES |
|---|
Like many drugs, metronidazole is relatively inactive until it is metabolized within host or microbial cells (24, 48). Metronidazole is activated when reduced, and reduction occurs only under strongly reducing conditions (28, 43). In anaerobic or microaerophilic bacteria or luminal parasites, metronidazole is activated when it receives an electron from ferredoxin or flavodoxin that was reduced by POR (9, 36, 37, 40, 47, 61, 68, 72, 87, 88). POR, which may be detected by measuring the coenzyme A (CoA)-dependent reduction of methyl viologen, is inactivated by oxygen. Among microorganisms, there is nearly a one-to-one correspondence between the presence of POR activity and metronidazole sensitivity (64). An exception may be Mycobacterium tuberculosis under anaerobic conditions, where mycobacteria stop dividing and become susceptible to metronidazole (93). Most eukaryotes and eubacteria fail to activate metronidazole, because POR is absent (58). In humans, pyruvate dehydrogenase substitutes for POR, and only NADH is produced rather than reduced ferredoxin. Metronidazole is also reduced and activated in poorly oxygenated tissues, such as those in abscesses or necrotic centers of tumors (43). Activated metronidazole damages cells by forming protein and DNA adducts (28). DNA damage may be the basis for the carcinogenicity of metronidazole in lab animals, although the carcinogenicity of metronidazole in humans has not been demonstrated (21).
| |
FERMENTATION PATHWAYS OF LUMINAL PARASITES ARE SIMPLER THAN THOSE OF BACTERIA |
|---|
The fermentation enzymes of parasites, bacteria, cilia, and fungi living under anaerobic conditions are necessary to dispose of reducing equivalents (NADH or NADPH) which are generated during glycolysis (9, 16, 27, 61, 68). Amebic and giardia fermentation enzymes are present in the cytosol, while most fermentation enzymes of trichomonads are in hydrogenosomes (Fig. 2) (4, 5, 8, 9, 12, 36, 37, 40, 46, 61, 62, 68, 69, 77, 87, 88, 97). The fermentation of pyruvate to ethanol, CO2, and acetate (amebae and giardia) or to CO2, acetate, and H2 (trichomonads) begins in each parasite with POR (Fig. 2). POR catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA, producing CO2 and a reduced ferredoxin radical. Ferredoxins of giardia and amebae are 6 kDa (like those of anaerobic bacteria), while the ferredoxin of trichomonads is 12 kDa (like those of mitochondria) (37, 40, 87). In the absence of metronidazole or oxygen as an electron acceptor, reduced ferredoxin, which was produced in the reaction catalyzed by POR, donates its electron to NAD (amebae and giardia) and/or to protons to produce hydrogen gas (trichomonads) (12).
|
Some luminal parasites and anaerobic bacteria convert acetyl-CoA to acetaldehyde via a CoA-dependent acetaldehyde dehydrogenase (ALDHE), which is absent in humans and most other eukaryotes (Fig. 2) (16, 27, 29, 63, 68, 72, 77, 83, 97). A CoA-independent ALDH (ALDH2), which is located in human mitochondria, is inhibited by disulfuram (antabuse) (56). Amebae are able to convert acetaldehyde to ethanol via one of three alcohol dehydrogenases (ADHs), which include an NAD-dependent ADHE and NADP-dependent ADH1 and ADH3 (46, 68, 97). Amebic ALDHE and ADHE are potential targets for new drugs. A novel assay for antiamebic compounds uses an E. coli adhe mutant, which is complemented with the amebic adhe gene (99). Giardias have ALDHE and ADHE, which may be targets for new drugs, while trichomonads have a bacterium-like hydrogenase, which may be a target for new drugs (12, 77).
The fermentation pathways of facultative anaerobes, such as E. coli, and obligate anaerobes, such as Clostridium acetobutylicum, are much more complex than those of the luminal protozoa (Fig. 2) (16, 27). Although E. coli has a por gene, pyruvate is, for the most part, converted to acetyl-CoA and formate via a pyruvate-formate lyase (6). Anaerobic bacteria have the most complex sets of fermentation products (carbon dioxide, hydrogen, ethanol, butanol, acetate, butyrate, lactate, and acetone). An ongoing sequencing project of the G. lamblia genome and a proposed sequencing project of the E. histolytica genome are likely to reveal many more bacterium-like fermentation enzymes in these parasites (81).
| |
POR AND OTHER REDOX PROTEINS OF LUMINAL PROTOZOA ARE FUSION PEPTIDES |
|---|
Genes encoding longer peptides of higher eukaryotes are often
composed of multiple fused exons (exon-shuffling hypothesis) (19a). Luminal parasites have rare introns (amebae) or no
introns (giardia and trichomonads) (51, 81). This is
consistent with secondary loss of introns and the splicing apparatus
from giardia and trichomonads (introns-early hypothesis) or with
development of introns and the splicing apparatus after giardia and
trichomonads diverged from the main trunk of the eukaryotic tree
(introns-late hypothesis) (73). Genes encoding longer
peptides of fermentation enzymes of the luminal protozoa appear to be
constructed by fusion of bacterial genes within an operon (42,
72). For example, the PORs of the luminal parasites and of some
eubacteria are homodimers, composed of a 110-kDa peptide, which appears
to be the result of the fusion of four POR peptides present in
archaebacteria and H. pylori (Fig.
3). The group III microbial ADHs of some
bacteria, amebae, and giardia are in the C half of a fusion enzyme,
which contains the CoA-dependent ALDHE in the N half (29, 63, 72, 97). In Clostridium kluyveri, the ALDHE and ADHE are
encoded by separate genes on the same operon (83). Other
microbial group III ADHs are encoded by genes independent of ALDHE in
amebae (ADH3), E. coli, and C. acetobutylicum
(16, 27, 69). The amebic NNT, which is homologous to
mitochondrial and bacterial enzymes, is a fusion peptide composed of
two peptides that are homologous to
- and
-subunits of the
bacterial nicotinamide nucleotide transhydrogenase (NNT)
(100). However, homologues of
- and
-subunits of
bacterial NNT are reversed in NNTs of amebae and apicomplexa versus
those of higher eukaryotes (Fig. 4)
(95). This surprising result suggests different origins of
the amebic and mitochondrial NNTs (see below).
|
|
| |
GENES ENCODING FERMENTATION ENZYMES OF LUMINAL PARASITES MAY HAVE ORIGINATED FROM MULTIPLE BACTERIA |
|---|
Genes encoding the bacterium-like fermentation enzymes of the
luminal protozoa appear to have been horizontally transferred from
bacteria, a phenomenon highly unusual for nonmitochondrial proteins
(see below) (12, 31, 72, 80). Evidence for this horizontal
transfer includes the following. First, parasite enzymes show
remarkable amino acid sequence identities to bacterial fermentation enzymes. For example, amebic ADH1 showed >60% amino acid sequence identities with secondary ADHs of Clostridium beijerinckii
and Thermoanaerobacter brockii (39, 45, 46). The
amebic POR and ADHE showed 49% amino acid sequence identities to those
of Klebsiella pneumoniae and E. coli,
respectively (29, 72, 97). Second, in phylogenetic trees
parasite enzymes are present in groups or clades which contain
bacterial enzymes and no other eukaryotic enzymes (72). For
example, the amebic ADH3 was paired with an ADH predicted by an
E. coli open reading frame (Fig. 4) (6, 22, 69).
The very high bootstrap value (94 at node A) indicates that the genes
encoding the amebic ADH3 and the E. coli ADH share a recent
ancestor. Third, genes encoding fermentation proteins of the same
luminal parasite appear to derive from different bacteria. Amebic ADH3
is most similar to a gram-negative rod, amebic ADH1 is most similar to
gram-positive rods, while amebic ADHE is equally similar to
gram-negative and gram-positive rods (46, 72). Fourth, genes
encoding homologous peptides in different parasites appear to derive
from different bacteria. Amebic ferredoxin is most similar to that of
the archaebacterium Methanosarcina barkeri, giardia
ferredoxin is most similar to that of the
-proteobacterium Desulfovibrio desulfuricans, while trichomonad
ferredoxin is most similar to that of the
-proteobacterium
Pseudomonas putida (37, 40, 72, 87). Fifth,
connector regions of POR, which correspond to untranslated regions in
nonfused bacterial genes, are completely unalignable for amebae and
giardia (Fig. 3) (42, 72). This result is consistent with
differences in appearance and phylogeny between these luminal parasites.
It seems most likely then that genes encoding fermentation enzymes of luminal parasites were horizontally transferred from multiple bacteria a long time ago (72). Identification of these bacterial donors may be aided by an explosion of new microbial enzyme sequences predicted from numerous ongoing whole-genome sequencing projects (6). It is possible but less likely that multiple genes encoding homologous fermentation enzymes were present in a common eukaryotic ancestor and then were lost from all organisms except luminal parasites (61, 68). Whether these gene transfers occurred with a bacterial endosymbiont or by means of plasmids, phages, or virus cannot be determined (13, 31, 54). The luminal parasites are surrounded by bacteria, which they phagocytose (59). Further, some protozoa have unusual endosymbionts, while bacterial plasmids replicate under antibiotic selection in transfected amebae, giardia, and trichomonads (18, 25, 33, 44, 54, 79). Genes that encode pyrophosphate-dependent glycolytic enzymes of amebae and giardia and cellulose-degrading proteins of rumen ciliates also appear to have been horizontally transferred from bacteria (10, 14). The mammalian triose-phosphate isomerase gene may also have been horizontally transferred from bacteria (41). Conversely, eukaryotic gene segments encoding fibronectin 3 domains appear to have been horizontally transferred into eubacteria (50).
| |
FERMENTATION ENZYMES OF LUMINAL PARASITES RESEMBLE THOSE OF BACTERIA IN SPECIFICITY AND TERTIARY STRUCTURE |
|---|
The substrate and cofactor specificities of bacterium-like fermentation enzymes have been remarkably well conserved. For example, amebic, giardia, and bacterial ADHEs are iron and NAD dependent, prefer short-chain primary alcohols, and form paracrystalline arrays (29, 63, 77, 97). Amebic ADH1, which is a 40-kDa, zinc-dependent enzyme distantly related to liver ADHs, has the same specificity for NADP and secondary alcohols as the C. beijerinckii and T. brockii enzymes (39, 46, 98). These specificities are distinct from those of liver enzymes, which prefer NAD and primary alcohols. The tertiary structure of amebic ADH1, determined by X-ray diffraction of crystals of the recombinant enzyme, closely resembles those of the bacterial enzymes (45). For example, 16 of 17 residues present in the active site of amebic ADH1 are identical to those of the T. brockii enzyme (76). In contrast, the substrate specificities and tertiary structures of human ADHs differ dramatically from each other (38).
| |
HYDROGENOSOMES ARE MODIFIED MITOCHONDRIA IN WHICH ANAEROBIC FERMENTATION ENZYMES HAVE REPLACED ENZYMES OF OXIDATIVE PHOSPHORYLATION |
|---|
The endosymbiont hypothesis, one of the great ideas in cell
biology, suggests that mitochondria and chloroplasts derive from a
phagocytosed
-proteobacterium and a phagocytosed cyanobacterium, respectively (Fig. 5) (13, 31, 54,
96). Evidence for this idea includes sequences of rRNA genes,
which remain in the matrices of mitochondria, and sequences of heat
shock proteins such as Hsp60, which are targeted to mitochondria
(32, 34, 53). In T. vaginalis and in rumen fungi,
bacterium-like fermentation enzymes have replaced enzymes of oxidative
phosphorylation in a modified mitochondrion, the hydrogenosome (5,
11, 13, 33, 62). Like mitochondria, most hydrogenosomes have
double membranes and divide by segmentation, and one hydrogenosomal
genome has been identified (4). Further, trichomonad
hydrogenosomal heat shock proteins (Hsp10, Hsp60, and Hsp70) align with
mitochondrial heat shock proteins in phylogenetic trees
(11). Hydrogenosomal proteins are synthesized and directed
to hydrogenosomes via presequences which are similar to those of
nucleus-encoded mitochondrial proteins (8, 12, 17, 36, 40).
Although hydrogenosomal function is not essential for viability,
metronidazole-resistant trichomonads, which lack POR and hydrogenase
activities, grow very slowly (47). Hydrogenosomes of rumen
fungi have similar fermentation enzymes and presequences to those of
trichomonads (5, 33, 65, 92).
|
The presence of a mitochondrion-derived organelle in trichomonads, mitochondrial Hsp60 in giardia and amebae, and mitochondrial Hsp70 in microsporidia, all of which are at the root of the eukaryotic phylogenetic tree, suggests that all extant eukaryotes have a common ancestor that had the same mitochondrion-derived endosymbiont (Fig. 5) (5, 11, 15, 35, 70, 71). Although the structural proteins of the mitochondrion appear to have been conserved in hydrogenosomes, some of the enzymes inside are likely not of mitochondrial origin (e.g., POR and hydrogenase) (12, 36). As discussed above, it is likely that these fermentation enzymes derive from anaerobic bacteria (72).
| |
CRYPTIC MITOCHONDRION-DERIVED ORGANELLE OF AMEBAE |
|---|
E. histolytica has an Hsp60-associated, mitochondrion-derived organelle, called "crypton" because it was previously hidden and its function remains unclear (Fig. 5) (52). Evidence for the amebic crypton includes the following. The amebic Hsp60 is grouped with those of mitochondria and hydrogenosomes in phylogenetic trees (11, 15, 70, 71). Amebic Hsp60 is functional, as suggested by its induction by heat shock, its ability to complement an E. coli groEL mutant, and its organellar localization (34, 52). The necessity of the presequence for targeting the Hsp60 to the organelle suggests conserved mitochondrion-like transporters in the crypton (8, 17, 52). Conversely, cleavage of the Hsp60 presequence suggests a conserved mitochondrion-like endopeptidase in the crypton. As the amebic cryptons are small and few, the organelles most closely resemble the atrophic mitochondria of bloodstream trypanosomes or anaerobically grown yeast (91). The difference between the crypton and these atrophic mitochondria is that the latter become competent organelles, which are capable of oxidative phosphorylation, when trypanosomes move to the insect vector or yeasts are exposed to oxygen.
The apicoplast of toxoplasma and P. falciparum is another recently discovered parasite organelle (Fig. 5) (44). The apicoplast, which is surrounded by four membranes, derives from an endosymbiont alga that contained a chloroplast. Antibiotics such as clindamycin target protein-synthetic machinery within the apicoplast, which is absent in host cells (23). To date, giardia and microsporidia are the only eukaryotes which do not have an endosymbiont-derived organelle (Fig. 5) (1, 26). The giardia Hsp60 lacks the usual organelle-targeting presequences at its N terminus and has been localized to the cytosol (71, 84).
| |
MECHANISMS OF METRONIDAZOLE RESISTANCE AMONG LUMINAL PROTOZOA |
|---|
Resistance of bacteria to antibiotics is quick to develop, rapid in its geographic spread, and oftentimes complete, rendering the particular antibiotic and related compounds no longer useful (49). For example, the widespread use of metronidazole, which is cheap and available without prescription in the developing world, has led to metronidazole-resistant H. pylori (57). The mechanism of metronidazole resistance appears to be a null mutation in the H. pylori rdxA gene, which encodes an oxygen-insensitive NADPH nitroreductase (30). In contrast, nitroimidazole resistance in bacteroides is plasmid mediated (89).
Metronidazole resistance among luminal parasites has been slow to develop and has not yet become of great clinical importance. The reasons for this may include the following. First, luminal parasites are most likely diploid, so that changes in a single gene are not sufficient to confer drug resistance (101). Bacteria are haploid, as is the bloodstream stage of Plasmodium falciparum, which is notorious for its resistance to chloroquine and other antimalarials (3). Second, luminal parasites have few metabolic alternatives to POR, which activates metronidazole. Amebae and giardia lack lactate dehydrogenase and pyruvate decarboxylase, which are present in other eukaryotes (9, 60, 68, 90). Trichomonads have cytosolic lactate dehydrogenase, which may substitute for POR in parasites selected for high levels of metronidazole resistance in the lab (47). However, these metronidazole-resistant trichomonads grow extremely slowly, making their competitiveness in nature uncertain. Decreased expression of ferredoxin confers low-level resistance to metronidazole on clinical isolates of trichomonads, which is easiest to detect under microaerophilic conditions (47). Decreases in POR activity and changes in permeability are associated with metronidazole resistance in giardia (86). Increased expression of superoxide dismutase by amebae is associated with low-level metronidazole resistance and with stress (74). Third, overexpression of ATP-binding cassette (ABC) family transporters, which are also known as "multidrug resistance" (mdr) gene products, confers resistance to some hydrophobic drugs but does not confer resistance to metronidazole (7, 25). For example, amebae step selected for resistance to emetine overexpress at least two ABC family transporters (19). However, these emetine-resistant parasites are not more resistant to metronidazole, which is hydrophilic and therefore not transported by P-glycoprotein pumps (75).
| |
CONCLUSIONS |
|---|
|
|
|---|
Luminal protozoa and bacteria are killed by metronidazole because they share the same fermentation enzyme, POR. An implication of this observation is that other bacterium-like fermentation enzymes (e.g., ADHE and hydrogenase) may be targets for antiparasitic drugs.
Luminal protozoan parasites targeted by metronidazole are not living fossils of eukaryotic life under anaerobic conditions but, instead, are diverse eukaryotes which have adapted bacterial solutions to life in an anaerobic niche.
Genes encoding fermentation enzymes of luminal eukaryotes were most likely horizontally transferred from bacteria, even if the identity of the bacterial donor(s) and the timing of the transfer(s) are not clear.
All extant eukaryotes have a common ancestor, which had a mitochondrion. In luminal protozoa, this endosymbiont-derived organelle may be remodeled into a hydrogenosome (e.g., trichomonads and rumen fungi and ciliates), may be atrophic (e.g., amebic crypton), or may be lost (e.g., giardia and microsporidia).
Metronidazole resistance among clinical isolates of luminal protozoa is rare. The slow development of metronidazole resistance among luminal protozoa is likely secondary to their polyploidy and the absence of alternative fermentation pathways.
| |
ACKNOWLEDGMENT |
|---|
This work was supported in part by National Institutes of Health grant AI-33492.
| |
FOOTNOTES |
|---|
* Mailing address: Department of Immunology and Infectious Diseases, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115. Phone: (617) 432-4670. Fax: (617) 738-4914. E-mail: jsamuels{at}hsph.harvard.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Adam, R. D.
1991.
The biology of Giardia spp.
Microbiol. Rev.
55:706-732 |
| 2. | Bakker-Grunwald, T., and C. Wostmann. 1993. Entamoeba histolytica as a model for the primitive eukaryotic cell. Parasitol. Today 9:27-31. [Medline] |
| 3. | Barat, L. M., and P. B. Bloland. 1997. Drug resistance among malaria and other parasites. Infect. Dis. Clin. N. Am. 11:969-987[Medline]. |
| 4. | Benchimol, M., P. J. Johnson, and W. de Souza. 1996. Morphogenesis of the hydrogenosome: an ultrastructural study. Biol. Cell 87:197-205[Medline]. |
| 5. | Biagini, G. A., B. J. Findlay, and D. J. Lloyd. 1997. Evolution of the hydrogenosome. FEMS Microbiol. Lett. 155:133-140[Medline]. |
| 6. |
Blattner, F. R.,
G. Plunkett,
C. A. Bloch,
N. T. Perna,
V. Burland,
M. Riley,
J. Collado-Vides,
J. D. Glasner,
C. K. Rode,
G. F. Mayhew,
J. Gregor,
N. W. Davis,
H. A. Kirkpatrick,
M. A. Goeden,
D. J. Rose,
B. Mau, and Y. Shao.
1997.
The complete genome sequence of Escherichia coli K-12.
Science
277:1453-1474 |
| 7. | Borst, P., and M. Ouellette. 1995. New mechanisms of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49:427-460[Medline]. |
| 8. | Bradley, P. J., C. J. Lahti, E. Plumper, and P. J. Johnson. 1997. Targeting and translocation of proteins into the hydrogenosome of the protist Trichomonas: similarities with mitochondrial protein import. EMBO J. 16:3484-3493[Medline]. |
| 9. | Brown, D. M., J. A. Upcroft, M. R. Edwards, and P. Upcroft. 1998. Anaerobic bacterial metabolism in the ancient eukaryote Giardia duodenalis. Int. J. Parasitol. 28:149-164[Medline]. |
| 10. | Bruchhaus, I., and E. Tannich. 1993. Primary structure of the pyruvate phosphate dikinase in Entamoeba histolytica. Mol. Biochem. Parasitol. 62:153-156[Medline]. |
| 11. |
Bui, E. T. N.,
P. J. Bradley, and P. J. Johnson.
1996.
A common evolutionary origin for mitochondria and hydrogenosomes.
Proc. Natl. Acad. Sci. USA
93:9651-9656 |
| 12. | Bui, E. T., and P. J. Johnson. 1996. Identification and characterization of [Fe]-hydrogenases in the hydrogenosome of Trichomonas vaginalis. Mol. Biochem. Parasitol. 76:305-310[Medline]. |
| 13. | Cavalier-Smith, T. 1987. The simultaneous symbiotic origin of mitochondria, chloroplasts, and microbodies. Ann. N. Y. Acad. Sci. 503:55-72[Medline]. |
| 14. |
Chen, H.,
X. L. Li, and L. G. Ljungdahl.
1997.
Sequencing of a 1,3-1,4-beta-D-glucanase (lichenase) from the anaerobic fungus Orpinomyces strain PC-2: properties of the enzyme expressed in Escherichia coli and evidence that the gene has a bacterial origin.
J. Bacteriol.
179:6028-6034 |
| 15. |
Clark, C. G., and A. J. Roger.
1995.
Direct evidence for secondary loss of mitochondria in Entamoeba histolytica.
Proc. Natl. Acad. Sci. USA
92:6518-6521 |
| 16. | Clark, D. P. 1989. The fermentation pathways of Escherichia coli. FEMS Microbiol. Rev. 5:223-234[Medline]. |
| 17. | Claros, M. G., and P. Vincens. 1996. Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur. J. Biochem. 241:779-786[Medline]. |
| 18. |
Delgadillo, M. G.,
D. R. Liston,
K. Niazi, and P. J. Johnson.
1997.
Transient and selectable transformation of the parasitic protist Trichomonas vaginalis.
Proc. Natl. Acad. Sci. USA
94:4716-4720 |
| 19. | Descoteaux, S., P. Ayala, J. Samuelson, and E. Orozco. 1995. Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene 164:179-184[Medline]. |
| 19a. |
de Souza, S. J.,
M. Long,
R. J. Klein,
S. Roy,
S. Lin, and W. Gilbert.
1998.
Toward a resolution of the introns early/late debate: only phase zero introns are correlated with the structure of ancient proteins.
Proc. Natl. Acad. Sci. USA
95:5094-5099 |
| 20. | Embley, T. M., B. J. Finlay, P. L. Dyal, R. P. Hirt, M. Wilkinson, and A. G. Williams. 1995. Multiple origins of anaerobic ciliates with hydrogenosomes within the radiation of aerobic ciliates. Proc. R. Soc. Lond. Ser. B 262:87-93[Medline]. |
| 21. | Falagas, M. E., A. M. Walker, H. Jick, R. Ruthazer, J. Griffith, and D. R. Snydman. 1998. Late incidence of cancer after metronidazole use: a matched metronidazole user/nonuser study. Clin. Infect. Dis. 26:384-388[Medline]. |
| 22. |
Felsenstein, J.
1989.
PHYLIP phylogeny inference package (version 3.2).
Cladistics
5:164-166.
|
| 23. | Fichera, M. E., and D. S. Roos. 1997. A plastid organelle as a drug target in apicomplexan parasites. Nature 390:407-409[Medline]. |
| 24. | Freeman, C. D., N. E. Klutman, and K. C. Lamp. 1997. Metronidazole. A therapeutic review and update. Drugs 54:679-708[Medline]. |
| 25. | Ghosh, S. K., A. Lohia, A. Kumar, and J. Samuelson. 1996. Overexpression of P-glycoprotein gene 1 by transfected Entamoeba histolytica confers emetine-resistance. Mol. Biochem. Parasitol. 82:257-260[Medline]. |
| 26. | Gillin, F. D., D. S. Reiner, and J. M. McCaffery. 1996. Cell biology of the primitive eukaryote Giardia lamblia. Annu. Rev. Microbiol. 50:679-705[Medline]. |
| 27. | Girbal, L., C. Croux, I. Vasconcelos, and P. Soucaille. 1995. Regulation of metabolic shifts in Clostridium acetobutylicum ATCC 824. FEMS Microbiol. Rev. 17:287-297. |
| 28. | Goldman, P., R. L. Koch, T. C. Yeung, E. J. Chrystal, B. B. Beaulieu, Jr., M. A. McLafferty, and G. Sudlow. 1986. Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity. Biochem. Pharmacol. 35:43-51[Medline]. |
| 29. | Goodlove, P. E., P. R. Cunningham, J. Parker, and D. P. Clark. 1989. Cloning and sequence analysis of the fermentative alcohol-dehydrogenase-encoding gene of Escherichia coli. Gene 85:209-214[Medline]. |
| 30. | Goodwin, A., D. Kersulyte, G. Sisson, S. J. Veldhuyzen van Zanten, D. E. Berg, and P. S. Hoffman. 1998. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol. Microbiol. 28:383-393[Medline]. |
| 31. |
Gray, M. W., and W. F. Doolittle.
1982.
Has the endosymbiont hypothesis been proven?
Microbiol. Rev.
46:1-42 |
| 32. | Gupta, R. S. 1995. Evolution of the chaperonin families (Hsp60, Hsp10 and Tcp-1) of proteins and the origin of eukaryotic cells. Mol. Microbiol. 15:1-11[Medline]. |
| 33. | Hackstein, J. H., and G. D. Vogels. 1997. Endosymbiotic interactions in anaerobic protozoa. Antonie Leeuwenhoek 71:151-158. |
| 34. | Hartl, F. U. 1996. Molecular chaperones in cellular protein folding. Nature 381:571-580[Medline]. |
| 35. | Hirt, R. P., B. Healy, C. R. Vossbrinck, C. R. Canning, and T. M. Embley. 1997. A mitochondrial Hsp70 orthologue in Vairimorpha necatrix: evidence that microsporidia once contained mitochondria. Curr. Biol. 7:995-998[Medline]. |
| 36. | Hrdy, I., and M. Muller. 1995. Primary structure and eubacterial relationship of the pyruvate:ferredoxin oxidoreductase of the amitochondriate eukaryote Trichomonas vaginalis. J. Mol. Evol. 41:388-396[Medline]. |
| 37. | Huber, M., L. Garfinkel, C. Gitler, D. Mirelman, M. Revel, and S. Rozenblatt. 1988. Nucleotide sequence analysis of an Entamoeba histolytica ferredoxin gene. Mol. Biochem. Parasitol. 31:27-34[Medline]. |
| 38. | Hurley, T. D., C. G. Steinmetz, P. Xie, and Y. N. Yang. 1997. Three-dimensional structures of human alcohol dehydrogenase isoenzymes reveal the molecular basis for their functional diversity. Adv. Exp. Med. Biol. 414:291-302[Medline]. |
| 39. |
Ismaiel, A. A.,
C. X. Zhu,
G. D. Colby, and J. S. Chen.
1993.
Purification and characterization of a primary-secondary alcohol dehydrogenase from two strains of Clostridium beijerinckii.
J. Bacteriol.
175:5097-5105 |
| 40. |
Johnson, P. J.,
C. E. D'Oliveira,
T. E. Gorrell, and M. Muller.
1990.
Molecular analysis of the hydrogenosomal ferredoxin of the anaerobic protist Trichomonas vaginalis.
Proc. Natl. Acad. Sci. USA
87:6097-6101 |
| 41. |
Keeling, P. J., and W. F. Doolittle.
1997.
Evidence that eukaryotic triosephosphate isomerase is of alpha-proteobacterial origin.
Proc. Natl. Acad. Sci. USA
94:1270-1275 |
| 42. |
Kletzin, A., and M. W. W. Adams.
1996.
Molecular and phylogenetic characterization of pyruvate and 2-ketoisovalerate ferredoxin oxidoreductases from Pyrococcus furiosus and pyruvate ferredoxin oxidoreductase from Thermotoga maritima.
J. Bacteriol.
178:248-257 |
| 43. | Koch, C. J., E. M. Lord, I. M. Shapiro, R. I. Clyman, and S. M. Evans. 1997. Imaging hypoxia and blood flow in normal tissues. Adv. Exp. Med. Biol. 428:585-593[Medline]. |
| 44. |
Kohler, S.,
C. F. Delwiche,
P. W. Denny,
L. G. Tilney,
P. Webster,
R. J. Wilson,
J. D. Palmer, and D. S. Roos.
1997.
A plastid of probable green algal origin in apicomplexan parasites.
Science
275:1485-1489 |
| 45. |
Korkhin, Y.,
F. Frolow,
O. Bogin,
M. Peretz,
A. J. Kalb, and Y. Burstein.
1996.
Crystalline alcohol dehydrogenases from the mesophilic bacterium Clostridium beijerinckii and the thermophilic bacterium Thermoanaerobium brockii preparation, characterization and molecular symmetry.
Acta Crystallogr. Sect. D
52:882-886.
|
| 46. | Kumar, A., P.-S. Shen, S. Descoteaux, J. Pohl, G. Bailey, and J. Samuelson. 1992. Cloning and expression of an NADP+-dependent alcohol dehydrogenase gene of Entamoeba histolytica. Proc. Natl. Acad. Sci. USA 85:1782-1786. |
| 47. | Land, K. M., and P. J. Johnson. 1997. Molecular mechanisms underlying metronidazole resistance in trichomonads. Exp. Parasitol. 87:305-308[Medline]. |
| 48. | Lau, A. H., N. P. Lam, S. C. Piscitelli, L. Wilkes, and L. H. Danziger. 1992. Clinical pharmokinetics of metronidazole and other nitroimidazole anti-infectives. Clin. Pharmacokinet. 23:328-364[Medline]. |
| 49. | Levy, S. B. 1998. The challenge of antibiotic resistance. Sci. Am. 278:46-53[Medline]. |
| 50. | Little, E., P. Bork, and R. F. Doolittle. 1994. Tracing the spread of fibronectin type III domains in bacterial glycohydrolases. J. Mol. Evol. 39:631-643[Medline]. |
| 51. | Lohia, A., and J. Samuelson. 1993. Cloning of the Eh cdc2 gene from Entamoeba histolytica encoding a protein kinase p34cdc2 homologue. Gene 127:203-207[Medline]. |
| 52. |
Mai, Z.,
S. Ghosh,
M. Frisardi,
B. Rosenthal,
R. Rogers, and J. Samuelson.
1999.
Hsp60 is targeted to a cryptic mitochondrion-derived organelle ("crypton") in the microaerophilic protozoan parasite Entamoeba histolytica.
Mol. Cell Biol.
19:2198-2205 |
| 53. |
Maidak, B. L.,
G. J. Olsen,
N. Larsen,
R. Overbeek,
M. J. McCaughey, and C. R. Woese.
1997.
The RDP (Ribosomal Database Project).
Nucleic Acids Res.
25:109-110 |
| 54. | Margulis, L. 1981. Symbiosis in cell evolution. W. H. Freeman & Co., New York, N.Y. |
| 55. | Martinez-Palomo, A. 1982. Cell biology, p. 5-59. In K. N. Brown (ed.), The biology of Entamoeba histolytica. John Wiley Research Studies Press, New York, N.Y. |
| 56. | Mays, D. C., P. Ortiz-Bermudez, J. P. Lam, I. H. Tong, A. H. Fauq, and J. J. Lipsky. 1998. Inhibition of recombinant human mitochondrial aldehyde dehydrogenase by two intermediate metabolites of disulfiram. Biochem. Pharmacol. 55:1099-1103[Medline]. |
| 57. |
Megraud, F., and H. P. Doermann.
1998.
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data.
Gut
43:S61-S65 |
| 58. | Mewes, H. W., K. Albermann, M. Bahr, D. Frishman, A. Gleissner, J. Hani, K. Heumann, K. Kleine, A. Maierl, S. G. Oliver, F. Pfeiffer, and A. Zollner. 1997. Overview of the yeast genome. Nature 387:7-65[Medline]. |
| 59. |
Mirelman, D.
1987.
Ameba-bacterium relationship in amebiasis.
Microbiol. Rev.
51:272-284 |
| 60. | Mucke, U., T. Wohlfarth, U. Fiedler, H. Baumlein, K. P. Rucknagel, and S. Konig. 1996. Pyruvate decarboxylase from Pisum sativum. Eur. J. Biochem. 237:373-382[Medline]. |
| 61. | Muller, M. 1992. Energy metabolism of ancestral eukaryotes: a hypothesis based on the biochemistry of amitochondriate parasitic proteins. BioSystems 28:33-40[Medline]. |
| 62. | Muller, M. 1993. The hydrogenosome. J. Gen. Microbiol. 139:2879-2889[Medline]. |
| 63. |
Nair, R. V.,
G. N. Bennett, and E. Papoutsakis.
1994.
Molecular characterization of an aldehyde/alcohol dehydrogenase gene from Clostridium acetobutylicum ATCC 824.
J. Bacteriol.
176:871-885 |
| 64. |
Narikawa, S.
1986.
Distribution of metronidazole susceptibility factors in obligate anaerobes.
J. Antimicrob. Chemother.
18:565-574 |
| 65. | Paul, R. G., A. G. Williams, and R. D. Butler. 1990. Hydrogenosomes in the rumen entodiniomorphid ciliate Polyplastron multivesiculatum. J. Gen. Microbiol. 136:1981-1999[Medline]. |
| 66. |
Petrin, D.,
K. Delgaty,
R. Bhatt, and G. Garber.
1998.
Clinical and microbiological aspects of Trichomonas vaginalis.
Clin. Microbiol. Rev.
11:300-317 |
| 67. | Ravdin, J. I. 1995. Amebiasis. State-of-the-art clinical article. Clin. Infect. Dis. 20:1453-1464[Medline]. |
| 68. | Reeves, R. E. 1984. Metabolism of Entamoeba histolytica Schaudinn, 1903. Adv. Parasitol. 23:105-142[Medline]. |
| 69. | Rodriguez, M. A., M. Baez-Camargo, D. M. Delgadillo, and E. Orozco. 1996. Cloning and expression of an Entamoeba histolytica NADP+-dependent alcohol dehydrogenase gene. Biochim. Biophys. Acta 1306:23-26[Medline]. |
| 70. |
Roger, A. J.,
C. G. Clark, and W. F. Doolittle.
1996.
A possible mitochondrial gene in the early-branching amitochondriate protist Trichomonas vaginalis.
Proc. Natl. Acad. Sci. USA
93:14618-14622 |
| 71. |
Roger, A. J.,
S. G. Svard,
J. Tovar,
C. G. Clark,
M. W. Smith,
F. D. Gillen, and M. L. Sogin.
1998.
A mitochondrial-like chaperonin 60 gene in Giardia lamblia: evidence that diplomonads once harbored an endosymbiont related to the progenitor of mitochondria.
Proc. Natl. Acad. Sci. USA
95:229-234 |
| 72. |
Rosenthal, B.,
Z. Mai,
D. Caplivski,
S. Ghosh,
H. de la Vega,
T. Graf, and J. Samuelson.
1997.
Evidence for the bacterial origin of genes encoding fermentation enzymes of the amitochondriate protozoan parasite Entamoeba histolytica.
J. Bacteriol.
179:3736-3745 |
| 73. |
Rzhetsky, A.,
F. J. Ayala,
L. C. Hsu,
C. Chang, and A. Yoshida.
1997.
Exon/intron structure of aldehyde dehydrogenase genes supports the "introns-late" theory.
Proc. Natl. Acad. Sci. USA
94:6820-6825 |
| 74. |
Samarawickrema, N. A.,
D. M. Brown,
J. A. Upcroft,
N. Thammapalerd, and P. Upcroft.
1997.
Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica.
J. Antimicrob. Chemother.
40:833-840 |
| 75. |
Samuelson, J.,
A. Burke, and J. Courval.
1992.
Susceptibility of an emetine-resistant mutant of Entamoeba histolytica to multiple drugs and to channel blockers.
Antimicrob. Agents Chemother.
36:2392-2397 |
| 76. | Samuelson, J., and J. F. Head. Unpublished data. |
| 77. | Sanchez, L. B. 1998. Aldehyde dehydrogenase (CoA-acetylating) and the mechanisms of ethanol formation in the amitochondriate protist, Giardia lamblia. Arch. Biochem. Biophys. 354:57-64[Medline]. |
| 78. | Shinn, D. L. S. 1962. Metronidazole in acute ulcerative gingivitis. Lancet i:1191. |
| 79. | Singer, S. M., J. Yee, and T. E. Nash. 1998. Episomal and integrated maintenance of foreign DNA in Giardia lamblia. Mol. Biochem. Parasitol. 92:59-69[Medline]. |
| 80. | Smith, M. W., D.-F. Feng, and R. F. Doolittle. 1992. Evolution by acquisition: the case for horizontal gene transfers. Trends Biochem. Sci. 17:489-493[Medline]. |
| 81. | Smith, M. W., S. B. Aley, M. Sogin, F. D. Gillin, and G. A. Evans. 1998. Sequence survey of the Giardia lamblia genome. Mol. Biochem. Parasitol. 95:267-280[Medline]. |
| 82. | Sogin, M. L., and J. D. Silberman. 1998. Evolution of the protists and protistan parasites from the perspective of molecular systematics. Int. J. Parasitol. 28:11-20[Medline]. |
| 83. |
Sohling, B., and G. Gottschalk.
1996.
Molecular analysis of the anaerobic succinate degradation pathway in Clostridium kluyveri.
J. Bacteriol.
178:871-880 |
| 84. | Soltys, B. J., and R. S. Gupta. 1994. Presence and cellular distribution of a 60-kDa protein related to mitochondrial HSP60 in Giardia lamblia. J. Parasitol. 80:580-590[Medline]. |
| 85. | Song, F., and A. M. Glenny. 1998. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br. J. Surg. 85:1232-1241[Medline]. |
| 86. | Townson, S. M., P. F. L. Borehman, P. Upcroft, and J. A. Upcroft. 1994. Resistance to nitroheterocyclic drugs. Acta Trop. 56:173-194[Medline]. |
| 87. | Townson, S. M., G. R. Hanson, J. A. Upcroft, and P. Upcroft. 1994. A purified ferredoxin from Giardia duodenalis. Eur. J. Biochem. 220:439-446[Medline]. |
| 88. | Townson, S. M., J. A. Upcroft, and P. Upcroft. 1996. Characterization and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. Mol. Biochem. Parasitol. 79:183-193[Medline]. |
| 89. | Trinh, S., and G. Reysset. 1996. Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp. J. Clin. Microbiol. 34:2078-2084[Abstract]. |
| 90. |
Tsuji, S.,
M. A. Qureshi,
E. W. Hou,
W. M. Fitch, and S. S.-L. Li.
1994.
Evolutionary relationships of lactate dehydrogenases (LDHs) from mammals, birds, an amphibian, fish, barley, and bacteria: LDH cDNA sequences from Xenopus, pig, and rat.
Proc. Natl. Acad. Sci. USA
91:9392-9396 |
| 91. | Tyler, K. M., K. R. Matthews, and K. Gull. 1997. The bloodstream differentiation-division of Trypanosoma brucei studied using mitochondrial markers. Proc. R. Soc. Lond. Ser. B 264:1481-1490[Medline]. |
| 92. | van der Giezen, M., K. B. Rechinger, I. Svendsen, R. Durand, R. P. Hirt, M. Fevre, T. M. Embley, and R. A. Prins. 1997. A mitochondrial-like targeting signal on the hydrogenosomal malic enzyme from the anaerobic fungus Neocallimastix frontalis: support for hypothesis that hydrogenosomes are modified mitochondria. Mol. Microbiol. 23:11-21[Medline]. |
| 93. |
Wayne, L. G., and H. A. Sramek.
1994.
Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.
Antimicrob. Agents Chemother.
38:2054-2058 |
| 94. |
Wilcox, M. H.
1998.
Treatment of Clostridium difficile infection.
J. Antimicrob. Chemother.
41C:41-46 |
| 95. |
Yamaguchi, M.,
Y. Hatefi,
K. Trach, and J. A. Hoch.
1988.
The primary structure of the mitochondrial energy-linked nicotinamide nucleotide transhydrogenase deduced from the sequence of cDNA clones.
J. Biol. Chem.
263:2761-2767 |
| 96. |
Yang, D.,
Y. Oyaizu,
H. Oyaizu,
G. J. Olsen, and C. R. Woese.
1985.
Mitochondrial origins.
Proc. Natl. Acad. Sci. USA
82:4443-4447 |
| 97. | Yang, W., E. Li, T. Kairong, and S. L. Stanley, Jr. 1994. Entamoeba histolytica has an alcohol dehydrogenase homologous to the multifunctional adhE gene product of Escherichia coli. Mol. Biochem. Parasitol. 64:253-260[Medline]. |
| 98. | Yokoyama, S., R. Yokoyama, C. S. Kinlaw, and D. E. Harry. 1990. Molecular evolution of zinc-containing long-chain alcohol genes. Mol. Biol. Evol. 7:143-154[Abstract]. |
| 99. |
Yong, T. S.,
E. Li,
D. Clark, and S. L. Stanley, Jr.
1996.
Complementation of an Escherichia coli adhE mutant by the Entamoeba histolytica EhADH2 gene provides a method for the identification of new anti-amebic drugs.
Proc. Natl. Acad. Sci. USA
93:6464-6469 |
| 100. | Yu, Y., and J. Samuelson. 1994. Primary structure of an Entamoeba histolytica nicotinamide nucleotide transhydrogenase. Mol. Biochem. Parasitol. 68:323-328[Medline]. |
| 101. | Yuh, Y. S., J. Y. Liu, and M. F. Shaio. 1997. Chromosome number of Trichomonas vaginalis. J. Parasitol. 83:551-533[Medline]. |
| 102. | Zaat, J. O. M., T. G. Mank, and W. J. J. Assendelft. 1997. A systematic review on the treatment of giardiasis. Trop. Med. Int. Health 2:63-82[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||